LLX Solutions, a biopharmaceutical services company, was founded in 2010 by three experienced clinical trialists. After 10 years of growth, by the end of 2019, the company has around 90 statistician and statistical programmers, have served over 40 companies in the world. provides statistics , statistical programming, data management, CDISC implementation and Consulting services to the pharmaceutical, biotechnology, and medical device companies across United States. Its team has proven expertise in supporting global clinical trials for different sizes of companies in the United States in various therapeutic areas such as cardiology, oncology, rare disease, medical devices, pain, infectious diseases, neurology, allergy/immunology, endocrinology/metabolism, gastroenterology and pediatrics. It has helped multiple companies to successfully submit their trials to regulatory agents and their drugs get approved.
LLX Solutions’ core competencies are its employees. The key members have over 20 years of experience in the industry and have built excellent reputations in multiple pharmaceutical and biotech companies they served. Majority of employees are well trained in statistics and other analytic disciplines in colleges and graduate schools. With this background, LLX Solutions is committed to provide our clients with the highest quality and timely deliverables. We are dedicated to ensuring that our clients will get the best services from us.